{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T06:02:09Z","timestamp":1779861729072,"version":"3.53.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neurochondrin (NCDN) has been recently identified as overexpressed in liver metastatic colorectal cancer (CRC) cells compared to poorly metastatic isogenic counterparts. While its cellular function and role in cancer and CRC remain unknown, patient survival data indicate that elevated NCDN levels are associated with poor prognosis. After validating these observations in an independent patient cohort, we sought to investigate the role of NCDN in CRC progression using isogenic CRC cell models comprising poorly metastatic KM12C and liver-metastatic KM12SM cells, and poorly metastatic SW480 and lymph node-metastatic SW620 cells. Stable silencing of NCDN expression in these cell lines resulted in a significant reduction in their tumorigenic and metastatic properties in vitro. Furthermore, in vivo assays using nude mice and the KM12 cell model demonstrated that NCDN is essential for tumor initiation, growth, and liver metastasis of CRC cells. Proteomic profiling of NCDN-silenced cells uncovered a set of dysregulated proteins associated with cell adhesion, invasion, cell death, and differentiation, and mitochondrial dysfunction, emerging NCDN-PODXL-EZR axis as a critical mediator of CRC progression and involved in liver metastasis. Our findings position NCDN and their associated dysregulated proteins as drivers of CRC progression and promising targets for further investigation.<\/jats:p>","DOI":"10.1038\/s41419-026-08747-5","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:17:20Z","timestamp":1776417440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurochondrin drives colorectal cancer progression by modulating the PODXL\u2013Ezrin axis and mitochondrial function"],"prefix":"10.1038","volume":"17","author":[{"given":"Mar\u00eda","family":"Garranzo-Asensio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Carral-Ibarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Montero-Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0894-970X","authenticated-orcid":false,"given":"Marta","family":"G\u00f3mez de Cedr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5995-2677","authenticated-orcid":false,"given":"Javier","family":"Vel\u00e1zquez-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Dziakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Sanz-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Pov\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ram\u00edrez de Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9007-828X","authenticated-orcid":false,"given":"Javier","family":"Mart\u00ednez-Useros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Fern\u00e1ndez-Ace\u00f1ero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-1491","authenticated-orcid":false,"given":"Rub\u00e9n A.","family":"Bartolom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3539-7469","authenticated-orcid":false,"given":"Rodrigo","family":"Barderas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"8747_CR1","unstructured":"Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2024. Available from: https:\/\/gco.iarc.who.int\/today."},{"key":"8747_CR2","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"MR Stratton","year":"2009","unstructured":"Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458:719\u201324.","journal-title":"Nature"},{"key":"8747_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.65","volume":"1","author":"EJ Kuipers","year":"2015","unstructured":"Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, et al. Colorectal cancer. Nat Rev Dis Prim. 2015;1:15065.","journal-title":"Nat Rev Dis Prim"},{"key":"8747_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"8747_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"8747_CR6","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1053\/j.gastro.2008.07.076","volume":"135","author":"WM Grady","year":"2008","unstructured":"Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008;135:1079\u201399.","journal-title":"Gastroenterology"},{"key":"8747_CR7","doi-asserted-by":"publisher","first-page":"16365","DOI":"10.3390\/ijms140816365","volume":"14","author":"D Colussi","year":"2013","unstructured":"Colussi D, Brandi G, Bazzoli F, Ricciardiello L. Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci. 2013;14:16365\u201385.","journal-title":"Int J Mol Sci"},{"key":"8747_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7407190","volume":"2019","author":"E Pretzsch","year":"2019","unstructured":"Pretzsch E, Bosch F, Neumann J, Ganschow P, Bazhin A, Guba M, et al. Mechanisms of metastasis in colorectal cancer and metastatic organotropism: hematogenous versus peritoneal spread. J Oncol. 2019;2019:7407190.","journal-title":"J Oncol"},{"key":"8747_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-022-00922-2","volume":"7","author":"H Zhou","year":"2022","unstructured":"Zhou H, Liu Z, Wang Y, Wen X, Amador EH, Yuan L, et al. Colorectal liver metastasis: molecular mechanism and interventional therapy. Signal Transduct Target Ther. 2022;7:70.","journal-title":"Signal Transduct Target Ther"},{"key":"8747_CR10","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.1158\/1078-0432.CCR-08-0520","volume":"14","author":"B Sun","year":"2008","unstructured":"Sun B, Zhang S, Zhang D, Li Y, Zhao X, Luo Y, et al. Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer. Clin Cancer Res. 2008;14:7050\u20139.","journal-title":"Clin Cancer Res"},{"key":"8747_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/14789450.2023.2275681","volume":"20","author":"RA Bartolome","year":"2023","unstructured":"Bartolome RA, Casal JI. Proteomic profiling and network biology of colorectal cancer liver metastasis. Expert Rev Proteom. 2023;20:357\u201370.","journal-title":"Expert Rev Proteom"},{"key":"8747_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.747333","volume":"8","author":"YW Kwon","year":"2021","unstructured":"Kwon YW, Jo HS, Bae S, Seo Y, Song P, Song M, et al. Application of proteomics in cancer: recent trends and approaches for biomarkers discovery. Front Med. 2021;8:747333.","journal-title":"Front Med"},{"key":"8747_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1455602","volume":"15","author":"A Montero-Calle","year":"2024","unstructured":"Montero-Calle A, Garranzo-Asensio M, Moreno-Casbas MT, Campuzano S, Barderas R. Autoantibodies in cancer: a systematic review of their clinical role in the most prevalent cancers. Front Immunol. 2024;15:1455602.","journal-title":"Front Immunol"},{"key":"8747_CR14","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.1021\/acs.jproteome.3c00749","volume":"23","author":"A Montero-Calle","year":"2024","unstructured":"Montero-Calle A, Garranzo-Asensio M, Poves C, Sanz R, Dziakova J, Pelaez-Garcia A, et al. In-depth proteomic analysis of paraffin-embedded tissue samples from colorectal cancer patients revealed TXNDC17 and SLC8A1 as key proteins associated with the disease. J Proteome Res. 2024;23:4802\u201320.","journal-title":"J Proteome Res"},{"key":"8747_CR15","doi-asserted-by":"crossref","unstructured":"Mendes M, Pelaez-Garcia A, Lopez-Lucendo M, Bartolome RA, Calvino E, Barderas R, et al. Mapping the spatial proteome of metastatic cells in colorectal cancer. Proteomics 2017;17:1600325.","DOI":"10.1002\/pmic.201700094"},{"key":"8747_CR16","doi-asserted-by":"crossref","unstructured":"Solis-Fernandez G, Montero-Calle A, Martinez-Useros J, Lopez-Janeiro A, de Los Rios V, Sanz R, et al. Spatial proteomic analysis of isogenic metastatic colorectal cancer cells reveals key dysregulated proteins associated with lymph node, liver, and lung metastasis. Cells 2022;11:447.","DOI":"10.3390\/cells11030447"},{"key":"8747_CR17","first-page":"6863","volume":"48","author":"K Morikawa","year":"1988","unstructured":"Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res. 1988;48:6863\u201371.","journal-title":"Cancer Res"},{"key":"8747_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0304-3835(98)00201-8","volume":"131","author":"BS Kubens","year":"1998","unstructured":"Kubens BS, Zanker KS. Differences in the migration capacity of primary human colon carcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). Cancer Lett. 1998;131:55\u201364.","journal-title":"Cancer Lett"},{"key":"8747_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.903033","volume":"12","author":"A Montero-Calle","year":"2022","unstructured":"Montero-Calle A, Gomez de Cedron M, Quijada-Freire A, Solis-Fernandez G, Lopez-Alonso V, Espinosa-Salinas I, et al. Metabolic reprogramming helps to define different metastatic tropisms in colorectal cancer. Front Oncol. 2022;12:903033.","journal-title":"Front Oncol"},{"key":"8747_CR20","doi-asserted-by":"crossref","unstructured":"Montero-Calle A, Jimenez de Ocana S, Benavente-Naranjo R, Rejas-Gonzalez R, Bartolome RA, Martinez-Useros J, et al. Functional proteomics characterization of the role of SPRYD7 in colorectal cancer progression and metastasis. Cells 2023;12:2548.","DOI":"10.3390\/cells12212548"},{"key":"8747_CR21","doi-asserted-by":"publisher","first-page":"11495","DOI":"10.1093\/nar\/gkx937","volume":"45","author":"KW Ellens","year":"2017","unstructured":"Ellens KW, Christian N, Singh C, Satagopam VP, May P, Linster CL. Confronting the catalytic dark matter encoded by sequenced genomes. Nucleic Acids Res. 2017;45:11495\u2013514.","journal-title":"Nucleic Acids Res"},{"key":"8747_CR22","doi-asserted-by":"publisher","first-page":"15898","DOI":"10.1073\/pnas.1508380112","volume":"112","author":"N Perdigao","year":"2015","unstructured":"Perdigao N, Heinrich J, Stolte C, Sabir KS, Buckley MJ, Tabor B, et al. Unexpected features of the dark proteome. Proc Natl Acad Sci USA. 2015;112:15898\u2013903.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8747_CR23","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556\u2013W560.","journal-title":"Nucleic Acids Res"},{"key":"8747_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2337\/db20-1206","volume":"71","author":"M Garranzo-Asensio","year":"2022","unstructured":"Garranzo-Asensio M, Solis-Fernandez G, Montero-Calle A, Garcia-Martinez JM, Fiuza MC, Pallares P, et al. Seroreactivity against tyrosine phosphatase PTPRN links type 2 diabetes and colorectal cancer and identifies a potential diagnostic and therapeutic target. Diabetes. 2022;71:497\u2013510.","journal-title":"Diabetes"},{"key":"8747_CR25","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1158\/0008-5472.CAN-11-4090","volume":"72","author":"R Barderas","year":"2012","unstructured":"Barderas R, Bartolome RA, Fernandez-Acenero MJ, Torres S, Casal JI. High expression of IL-13 receptor alpha2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis. Cancer Res. 2012;72:2780\u201390.","journal-title":"Cancer Res"},{"key":"8747_CR26","doi-asserted-by":"crossref","unstructured":"Borowicz S, Van Scoyk M, Avasarala S, Karuppusamy Rathinam MK, Tauler J, Bikkavilli RK, et al. The soft agar colony formation assay. J Vis Exp 2014;27:e51998.","DOI":"10.3791\/51998"},{"key":"8747_CR27","doi-asserted-by":"crossref","unstructured":"Montero-Calle A, Garranzo-Asensio M, Rejas-Gonzalez R, Feliu J, Mendiola M, Pelaez-Garcia A, et al. Benefits of FAIMS to improve the proteome coverage of deteriorated and\/or cross-linked TMT 10-Plex FFPE tissue and plasma-derived exosomes samples. Proteomes 2023;11:35.","DOI":"10.3390\/proteomes11040035"},{"key":"8747_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2020.103635","volume":"214","author":"M Garranzo-Asensio","year":"2020","unstructured":"Garranzo-Asensio M, San Segundo-Acosta P, Poves C, Fernandez-Acenero MJ, Martinez-Useros J, Montero-Calle A, et al. Identification of tumor-associated antigens with diagnostic ability of colorectal cancer by in-depth immunomic and seroproteomic analysis. J Proteom. 2020;214:103635.","journal-title":"J Proteom"},{"key":"8747_CR29","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41416-022-01762-1","volume":"126","author":"G Solis-Fernandez","year":"2022","unstructured":"Solis-Fernandez G, Montero-Calle A, Sanchez-Martinez M, Pelaez-Garcia A, Fernandez-Acenero MJ, Pallares P, et al. Aryl-hydrocarbon receptor-interacting protein regulates tumorigenic and metastatic properties of colorectal cancer cells driving liver metastasis. Br J Cancer. 2022;126:1604\u201315.","journal-title":"Br J Cancer"},{"key":"8747_CR30","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41416-025-03184-1","volume":"133","author":"A Montero-Calle","year":"2025","unstructured":"Montero-Calle A, Jimenez de Ocana S, Rejas-Gonzalez R, Benavente-Naranjo R, Sanz-Lopez R, Dziakova J, et al. Deciphering the central role of TMOD2 in colorectal cancer progression and metastasis. Br J Cancer. 2025;133:1599\u2013610.","journal-title":"Br J Cancer"},{"key":"8747_CR31","first-page":"917","volume":"52","author":"DY Dy","year":"1992","unstructured":"Dy DY, Whitehead RH, Morris DL. SMS 201.995 inhibits in vitro and in vivo growth of human colon cancer. Cancer Res. 1992;52:917\u201323.","journal-title":"Cancer Res"},{"key":"8747_CR32","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1038\/s41388-021-01666-z","volume":"40","author":"Q Yan","year":"2021","unstructured":"Yan Q, Zeng P, Zhou X, Zhao X, Chen R, Qiao J, et al. RBMX suppresses tumorigenicity and progression of bladder cancer by interacting with the hnRNP A1 protein to regulate PKM alternative splicing. Oncogene. 2021;40:2635\u201350.","journal-title":"Oncogene"},{"key":"8747_CR33","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.celrep.2018.06.092","volume":"24","author":"J Frose","year":"2018","unstructured":"Frose J, Chen MB, Hebron KE, Reinhardt F, Hajal C, Zijlstra A, et al. Epithelial-mesenchymal transition induces podocalyxin to promote extravasation via ezrin signaling. Cell Rep. 2018;24:962\u201372.","journal-title":"Cell Rep"},{"key":"8747_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-8-61","volume":"8","author":"Y Meng","year":"2010","unstructured":"Meng Y, Lu Z, Yu S, Zhang Q, Ma Y, Chen J. Ezrin promotes invasion and metastasis of pancreatic cancer cells. J Transl Med. 2010;8:61.","journal-title":"J Transl Med"},{"key":"8747_CR35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nm982","volume":"10","author":"C Khanna","year":"2004","unstructured":"Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 2004;10:182\u20136.","journal-title":"Nat Med"},{"key":"8747_CR36","doi-asserted-by":"crossref","unstructured":"Huang CY, Wei PL, Batzorig U, Makondi PT, Lee CC, Chang YJ. Identification of Moesin (MSN) as a potential therapeutic target for colorectal cancer via the beta-catenin-RUNX2 axis. Int J Mol Sci 2023;24:10951.","DOI":"10.3390\/ijms241310951"},{"key":"8747_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/340271","volume":"2014","author":"QH Jiang","year":"2014","unstructured":"Jiang QH, Wang AX, Chen Y. Radixin enhances colon cancer cell invasion by increasing MMP-7 production via Rac1-ERK pathway. ScientificWorldJournal. 2014;2014:340271.","journal-title":"ScientificWorldJournal"},{"key":"8747_CR38","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/jgh.15195","volume":"36","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yang Y, Wang X, Jin T, Zhu G, Lin Z. Ezrin as a prognostic indicator regulates colon adenocarinoma progression through glycolysis. J Gastroenterol Hepatol. 2021;36:710\u201320.","journal-title":"J Gastroenterol Hepatol"},{"key":"8747_CR39","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.cellsig.2014.01.014","volume":"26","author":"PD Leiphrakpam","year":"2014","unstructured":"Leiphrakpam PD, Rajput A, Mathiesen M, Agarwal E, Lazenby AJ, Are C, et al. Ezrin expression and cell survival regulation in colorectal cancer. Cell Signal. 2014;26:868\u201379.","journal-title":"Cell Signal"},{"key":"8747_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0882-0","volume":"14","author":"AH Larsson","year":"2016","unstructured":"Larsson AH, Lehn S, Wangefjord S, Karnevi E, Kuteeva E, Sundstrom M, et al. Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer. J Transl Med. 2016;14:128.","journal-title":"J Transl Med"},{"key":"8747_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11033-023-08920-5","volume":"51","author":"J Yayan","year":"2024","unstructured":"Yayan J, Franke KJ, Berger M, Windisch W, Rasche K. Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review. Mol Biol Rep. 2024;51:165.","journal-title":"Mol Biol Rep"},{"key":"8747_CR42","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/onc.2013.117","volume":"33","author":"RA Bartolome","year":"2014","unstructured":"Bartolome RA, Barderas R, Torres S, Fernandez-Acenero MJ, Mendes M, Garcia-Foncillas J, et al. Cadherin-17 interacts with alpha2beta1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis. Oncogene. 2014;33:1658\u201369.","journal-title":"Oncogene"},{"key":"8747_CR43","doi-asserted-by":"crossref","unstructured":"Corbo C, Cevenini A, Salvatore F. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer. Proteomics Clin Appl 2017;11.","DOI":"10.1002\/prca.201600072"},{"key":"8747_CR44","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.jprot.2010.06.004","volume":"73","author":"CR Jimenez","year":"2010","unstructured":"Jimenez CR, Knol JC, Meijer GA, Fijneman RJ. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. J Proteom. 2010;73:1873\u201395.","journal-title":"J Proteom"},{"key":"8747_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188735","volume":"1877","author":"G Zhu","year":"2022","unstructured":"Zhu G, Jin L, Sun W, Wang S, Liu N. Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers. Biochim Biophys Acta Rev Cancer. 2022;1877:188735.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8747_CR46","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.ccell.2022.06.010","volume":"40","author":"E Goncalves","year":"2022","unstructured":"Goncalves E, Poulos RC, Cai Z, Barthorpe S, Manda SS, Lucas N, et al. Pan-cancer proteomic map of 949 human cell lines. Cancer Cell. 2022;40:835\u2013849 e838.","journal-title":"Cancer Cell"},{"key":"8747_CR47","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1042\/BST20221349","volume":"51","author":"SA Chetwynd","year":"2023","unstructured":"Chetwynd SA, Andrews S, Inglesfield S, Delon C, Ktistakis NT, Welch HCE. Functions and mechanisms of the GPCR adaptor protein Norbin. Biochem Soc Trans. 2023;51:1545\u201358.","journal-title":"Biochem Soc Trans"},{"key":"8747_CR48","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1126\/science.1178496","volume":"326","author":"H Wang","year":"2009","unstructured":"Wang H, Westin L, Nong Y, Birnbaum S, Bendor J, Brismar H, et al. Norbin is an endogenous regulator of metabotropic glutamate receptor 5 signaling. Science. 2009;326:1554\u20137.","journal-title":"Science"},{"key":"8747_CR49","doi-asserted-by":"publisher","first-page":"9745","DOI":"10.1073\/pnas.1510291112","volume":"112","author":"H Wang","year":"2015","unstructured":"Wang H, Warner-Schmidt J, Varela S, Enikolopov G, Greengard P, Flajolet M. Norbin ablation results in defective adult hippocampal neurogenesis and depressive-like behavior in mice. Proc Natl Acad Sci USA. 2015;112:9745\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8747_CR50","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/pathophysiology31020019","volume":"31","author":"B Aljeradat","year":"2024","unstructured":"Aljeradat B, Kumar D, Abdulmuizz S, Kundu M, Almealawy YF, Batarseh DR, et al. Neuromodulation and the gut-brain axis: therapeutic mechanisms and implications for gastrointestinal and neurological disorders. Pathophysiology. 2024;31:244\u201368.","journal-title":"Pathophysiology"},{"key":"8747_CR51","doi-asserted-by":"publisher","first-page":"e18715","DOI":"10.1371\/journal.pone.0018715","volume":"6","author":"X Meng","year":"2011","unstructured":"Meng X, Ezzati P, Wilkins JA. Requirement of podocalyxin in TGF-beta induced epithelial mesenchymal transition. PLoS One. 2011;6:e18715.","journal-title":"PLoS One"},{"key":"8747_CR52","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s10120-022-01305-w","volume":"25","author":"S Nishimura","year":"2022","unstructured":"Nishimura S, Yamamoto Y, Sugimoto A, Kushiyama S, Togano S, Kuroda K, et al. Lipocalin-2 negatively regulates epithelial-mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer. Gastric Cancer. 2022;25:850\u201361.","journal-title":"Gastric Cancer"},{"key":"8747_CR53","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/hep.26467","volume":"58","author":"YP Wang","year":"2013","unstructured":"Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, et al. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)\/Lcn2\/Twist1 pathway. Hepatology. 2013;58:1349\u201361.","journal-title":"Hepatology"},{"key":"8747_CR54","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1002\/ijc.22352","volume":"120","author":"R Lim","year":"2007","unstructured":"Lim R, Ahmed N, Borregaard N, Riley C, Wafai R, Thompson EW, et al. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer. 2007;120:2426\u201334.","journal-title":"Int J Cancer"},{"key":"8747_CR55","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1111\/cas.13389","volume":"108","author":"SL Kim","year":"2017","unstructured":"Kim SL, Lee ST, Min IS, Park YR, Lee JH, Kim DG, et al. Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer. Cancer Sci. 2017;108:2176\u201386.","journal-title":"Cancer Sci"},{"key":"8747_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-016-0564-9","volume":"15","author":"M Feng","year":"2016","unstructured":"Feng M, Feng J, Chen W, Wang W, Wu X, Zhang J, et al. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-kappaB-dependent activation of snail and epithelial mesenchymal transition. Mol Cancer. 2016;15:77.","journal-title":"Mol Cancer"},{"key":"8747_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-023-01564-1","volume":"16","author":"X Sun","year":"2023","unstructured":"Sun X, Zhang J, Hu J, Han Q, Ge Z. LSM2 is associated with a poor prognosis and promotes cell proliferation, migration, and invasion in skin cutaneous melanoma. BMC Med Genomics. 2023;16:129.","journal-title":"BMC Med Genomics"},{"key":"8747_CR58","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","volume":"19","author":"Y Xie","year":"2023","unstructured":"Xie Y, Kang R, Klionsky DJ, Tang D. GPX4 in cell death, autophagy, and disease. Autophagy. 2023;19:2621\u201338.","journal-title":"Autophagy"},{"key":"8747_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9145452","volume":"2019","author":"L Wu","year":"2019","unstructured":"Wu L, Ma F, Zhao X, Zhang MX, Wu J, Mi J. GNPDA2 gene affects adipogenesis and alters the transcriptome profile of human adipose-derived mesenchymal stem cells. Int J Endocrinol. 2019;2019:9145452.","journal-title":"Int J Endocrinol"},{"key":"8747_CR60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216713120","volume":"120","author":"Z Du","year":"2023","unstructured":"Du Z, Zhou X, Lai Y, Xu J, Zhang Y, Zhou S, et al. Structure of the human respiratory complex II. Proc Natl Acad Sci USA. 2023;120:e2216713120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8747_CR61","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mito.2021.08.005","volume":"60","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Zhang K, Liu Z, Gao X, Huang K, Chen C, et al. ATPAF1 deficiency impairs ATP synthase assembly and mitochondrial respiration. Mitochondrion. 2021;60:129\u201341.","journal-title":"Mitochondrion"},{"key":"8747_CR62","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1111\/jcmm.17813","volume":"27","author":"T Liu","year":"2023","unstructured":"Liu T, Zhu H, Ge M, Pan Z, Zeng Y, Leng Y, et al. GPD1L inhibits renal cell carcinoma progression by regulating PINK1\/Parkin-mediated mitophagy. J Cell Mol Med. 2023;27:2328\u201339.","journal-title":"J Cell Mol Med"},{"key":"8747_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bjd.12208","volume":"169","author":"MD Brand","year":"2013","unstructured":"Brand MD, Orr AL, Perevoshchikova IV, Quinlan CL. The role of mitochondrial function and cellular bioenergetics in ageing and disease. Br J Dermatol. 2013;169:1\u20138.","journal-title":"Br J Dermatol"},{"key":"8747_CR64","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s13046-022-02477-0","volume":"41","author":"L Wang","year":"2022","unstructured":"Wang L, Li S, Luo H, Lu Q, Yu S. PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K\/AKT signaling in tumor cells and phenotypic polarization of macrophages. J Exp Clin Cancer Res. 2022;41:303.","journal-title":"J Exp Clin Cancer Res"},{"key":"8747_CR65","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3892\/ol.2023.14086","volume":"26","author":"H Wang","year":"2023","unstructured":"Wang H, Guo Q, Wang M, Liu C, Tian Z. PCSK9 promotes tumor cell proliferation and migration by facilitating CCL25 secretion in esophageal squamous cell carcinoma. Oncol Lett. 2023;26:500.","journal-title":"Oncol Lett"},{"key":"8747_CR66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41392-021-00597-1","volume":"6","author":"S Gao","year":"2021","unstructured":"Gao S, Zhang LS, Wang L, Xiao NN, Long H, Yin YL, et al. RHBDF1 promotes AP-1-activated endothelial-mesenchymal transition in tumor fibrotic stroma formation. Signal Transduct Target Ther. 2021;6:273.","journal-title":"Signal Transduct Target Ther"},{"key":"8747_CR67","doi-asserted-by":"publisher","first-page":"66660","DOI":"10.18632\/oncotarget.11433","volume":"7","author":"L Hu","year":"2016","unstructured":"Hu L, Wang RY, Cai J, Feng D, Yang GZ, Xu QG, et al. Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma. Oncotarget. 2016;7:66660\u201378.","journal-title":"Oncotarget"},{"key":"8747_CR68","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.gene.2018.02.007","volume":"654","author":"P Gao","year":"2018","unstructured":"Gao P, He M, Zhang C, Geng C. Integrated analysis of gene expression signatures associated with colon cancer from three datasets. Gene. 2018;654:95\u2013102.","journal-title":"Gene"},{"key":"8747_CR69","doi-asserted-by":"crossref","unstructured":"Sipos F, Muzes G. Interconnection of CD133 stem cell marker with autophagy and apoptosis in colorectal cancer. Int J Mol Sci 2024;25:11201.","DOI":"10.3390\/ijms252011201"},{"key":"8747_CR70","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature11648","volume":"492","author":"J Nandakumar","year":"2012","unstructured":"Nandakumar J, Bell CF, Weidenfeld I, Zaug AJ, Leinwand LA, Cech TR. The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature. 2012;492:285\u20139.","journal-title":"Nature"},{"key":"8747_CR71","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-18-0099","volume":"27","author":"J Li","year":"2018","unstructured":"Li J, Chang J, Tian J, Ke J, Zhu Y, Yang Y, et al. A rare variant P507L in TPP1 interrupts TPP1-TIN2 interaction, influences telomere length, and confers colorectal cancer risk in the Chinese population. Cancer Epidemiol Biomark Prev. 2018;27:1029\u201335.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"8747_CR72","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.breast.2018.03.015","volume":"39","author":"A Gangadharan","year":"2018","unstructured":"Gangadharan A, Nyirenda T, Patel K, Jaimes-Delgadillo N, Coletta D, Tanaka T, et al. Prolactin induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer. Breast. 2018;39:101\u20139.","journal-title":"Breast"},{"key":"8747_CR73","doi-asserted-by":"crossref","unstructured":"Tian X, Gu L, Zeng F, Liu X, Zhou Y, Dou Y, et al. Strophanthidin induces apoptosis of human lung adenocarcinoma cells by promoting TRAIL-DR5 signaling. Molecules 2024;29:877.","DOI":"10.3390\/molecules29040877"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08747-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08747-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08747-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:03:08Z","timestamp":1779858188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08747-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8747"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08747-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were performed under the guidelines of the Instituto de Salud Carlos III Institutional Animal Care Committee. All experimental protocols were approved by the Committee (Proex 285\/19). The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Hospital Cl\u00ednico San Carlos and Instituto de Salud Carlos III (CEI PI 13_2020-v2 and CEI PI 90_2023). All authors of this article gave consent for the publication of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"511"}}